Asthma is an important medical, social and economical problem. 5–10% of all patients with
asthma constitute cases of severe asthma. One treatment method for severe asthma …

Aim To assess efficacy of omalizumab in moderate to severe asthma and notable factors
affecting it, such as treatment compliance during the period of ten years. This retrospective …

We describe the case of 31-year-old woman whose severe asthma was not properly
controlled with best available therapy according to GINA (2002). Following administration of …

Aim To assess the efficacy and safety of Omalizumab in all asthmatic patients who were
treated with Omalizumab during at least 3 months in the Pulmonary Department at the Meir …

Immunoglobulin E plays an important role in allergic diseases. In patients with allergic
asthma, exposure to allergens releases a wide range of proinflamatory mediators, which are …

We report the case of a 38-year-old woman suffering from allergic asthma since the age of 4.
In the last 10 years, the patient presented with severe uncontrolled asthma with frequent …

Implementation of omalizumab in the treatment of patients with severe allergic asthma
opened the possibility of obtaining optimal control of the disease and improving the quality …

OBJETIVES To describe the outcome of patients treated with Omalizumab-OMZ-for at least
16 weeks. METHODS A prospective study of asthmatic patients under treatment with OMZ in …

Rationale. Severe asthma is characterized by inadequate symptom control and by high rate
of inflammation despite high doses of steroids. Omalizumab, a recombinant humanized …